Kew, Australia

Jane Visvader



 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Jane Visvader

Introduction: Jane Visvader, an accomplished inventor based in Kew, Australia, has made significant contributions to the field of medical research and pharmaceuticals. With a strong focus on innovative methods for cell isolation and novel drug combinations, she holds three patents that demonstrate her expertise and commitment to advancing medical science.

Latest Patents: Jane Visvader's latest patents include a groundbreaking combination of a MCL-1 inhibitor and a taxane compound, which explores the therapeutic potential of this drug combination for pharmaceutical applications. Additionally, she has developed a method for cell isolation aimed at generating a substantially homogenous population of undifferentiated cells. This method is particularly effective for isolating mammary stem cells (MaSCs), which can serve as targets for identifying agents that modulate MaSC survival, self-renewal, proliferation, and differentiation in various tissue contexts, including tumor tissue.

Career Highlights: Throughout her career, Jane Visvader has worked with prestigious organizations, notably the Walter and Eliza Hall Institute of Medical Research and Les Laboratories Servier. Her work has been instrumental in enhancing our understanding of stem cell biology and its applications in regenerative medicine.

Collaborations: In her journey as an inventor, Jane Visvader has collaborated with notable colleagues, including Geoffrey Lindeman and Mark Shackleton. These collaborations have not only enriched her research but have also led to innovative breakthroughs in the medical field.

Conclusion: Jane Visvader exemplifies the spirit of innovation and dedication in the realm of medical research. Through her patents and collaborations, she continues to pave the way for advancements that have the potential to transform treatments in regenerative medicine and oncology. Her contributions are a testament to the impact of innovative thinking in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…